Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BIO
GMED
Add up to 3 more stocks
BIO
Bio-Rad Laboratories, Inc.
+0.33%
$389.94+1.30Delayed quote: Aug 27, 2026, 4:00 PM EDT
Market Cap
$10.50B
52W Range
$236.73 - $396.23
GMED
Globus Medical, Inc.
-0.67%
$82.54-0.56Delayed quote: Aug 27, 2026, 4:00 PM EDT
Market Cap
$11.13B
52W Range
$54.15 - $101.40
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 47.11 | 21.22 |
| Forward P/E | 40.31 | 16.57 |
| P/B Ratio | 1.45 | 2.39 |
| P/S Ratio | 4.02 | 3.63 |
| P/FCF Ratio | 29.51 | 15.20 |
| EV/EBITDA | 29.04 | 11.79 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 51.9% | 68.5% |
| Operating Margin | 9.1% | 20.8% |
| Net Margin | 8.6% | 17.0% |
| ROE | 3.1% | 11.2% |
| ROA | 2.2% | 9.8% |
| ROIC | 1.5% | 10.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 3.14 | 4.62 |
| Quick Ratio | 2.33 | 2.93 |
| Debt/Equity | 0.17 | 0.02 |
| Interest Coverage | 5.52 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.